UiPath (PATH) Form 144: Sale of 10,000 shares, $164,800

UiPath (PATH) filed a Form 144 notice for a proposed sale of restricted securities by an affiliate.

Rhea-AI Filing Summary

UiPath (PATH) filed a Form 144 notice for a proposed sale of restricted securities by an affiliate. The filing lists 10,000 common shares to be sold through Morgan Stanley Smith Barney, with an aggregate market value of $164,800, on or about 10/15/2025 on the NYSE. Shares outstanding were 453,568,899.

The shares were acquired as Restricted Stock Units from the issuer on 01/01/2024. The notice also reports recent activity under a 10b5-1 framework: on 10/14/2025, 10,000 shares sold for $165,351, and on 10/13/2025, 10,000 shares sold for $170,056.

Insights

Securities law analyst

Routine Rule 144 sale notice; administrative and neutral.

This Form 144 discloses an affiliate’s intent to sell 10,000 common shares of UiPath, acquired via Restricted Stock Units. Rule 144 requires advance notice when affiliates plan public sales above de minimis thresholds. The filing names Morgan Stanley Smith Barney as broker and NYSE as the venue.

The document also lists recent 10b5-1 sales: 10,000 shares on 10/14/2025 for $165,351 and 10,000 shares on 10/13/2025 for $170,056. Shares outstanding were 453,568,899, a baseline figure for context. Actual market impact depends on execution and volume, which are not detailed here.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PATH disclose in this Form 144?

A proposed sale of 10,000 common shares with an aggregate market value of $164,800, expected around 10/15/2025 on the NYSE.

How were the PATH shares acquired for this sale?

They were acquired as Restricted Stock Units from the issuer on 01/01/2024.

Who is the broker for the proposed PATH share sale?

The filing lists Morgan Stanley Smith Barney LLC as the broker.

What recent PATH stock sales are disclosed in the filing?

Reported 10b5-1 sales include 10,000 shares on 10/14/2025 for $165,351 and 10,000 shares on 10/13/2025 for $170,056.

How many PATH shares were outstanding?

453,568,899 shares were outstanding, as stated in the notice.

On which exchange will the PATH shares be sold?

The filing identifies the NYSE as the exchange.

What is the aggregate market value of the proposed PATH sale?

The notice states an aggregate market value of $164,800 for 10,000 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/15/2025 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001855764
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	UIPATH INC.
SEC File Number	001-40348
Address of Issuer	One Vanderbilt Avenue, 60th Floor New York NEW YORK 10017
Phone	8444320455
Name of Person for Whose Account the Securities are To Be Sold	HITESH RAMANI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	164800.00	453568899	10/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2024	Restricted Stock Units	Issuer			10000	01/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for HITESH RAMANI One Vanderbilt Avenue, 60th Floor New York NY 10017	Common	10/14/2025	10000	165351.00
10b5-1 Sales for HITESH RAMANI One Vanderbilt Avenue, 60th Floor New York NY 10017	Common	10/13/2025	10000	170056.00

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock units during the period of 01/01/2024 through 10/01/2025
Date of Notice	10/15/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Hitesh Ramani
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)